Fennec Pharmaceuticals Inc. (NASDAQ: FENC)
$6.1600
-0.0500 ( +0.16% ) 29.0K
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Market Data
Open
$6.1600
Previous close
$6.2100
Volume
29.0K
Market cap
$162.67M
Day range
$5.9610 - $6.2750
52 week range
$3.9600 - $11.9200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Dec 23, 2024 |
| 8-k | 8K-related | 16 | Dec 20, 2024 |
| 8-k | 8K-related | 15 | Dec 20, 2024 |
| 4 | Insider transactions | 1 | Dec 05, 2024 |
| 4 | Insider transactions | 1 | Dec 04, 2024 |
| 4 | Insider transactions | 1 | Dec 02, 2024 |
| 4 | Insider transactions | 1 | Dec 02, 2024 |
| 4 | Insider transactions | 1 | Nov 18, 2024 |
| 4 | Insider transactions | 1 | Nov 13, 2024 |
| 4 | Insider transactions | 1 | Nov 13, 2024 |